These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20031619)

  • 1. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation.
    Dellefave LM; Pytel P; Mewborn S; Mora B; Guris DL; Fedson S; Waggoner D; Moskowitz I; McNally EM
    Circ Cardiovasc Genet; 2009 Oct; 2(5):442-9. PubMed ID: 20031619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in sarcomere protein genes in left ventricular noncompaction.
    Klaassen S; Probst S; Oechslin E; Gerull B; Krings G; Schuler P; Greutmann M; Hürlimann D; Yegitbasi M; Pons L; Gramlich M; Drenckhahn JD; Heuser A; Berger F; Jenni R; Thierfelder L
    Circulation; 2008 Jun; 117(22):2893-901. PubMed ID: 18506004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomere mutations in cardiogenesis and ventricular noncompaction.
    McNally E; Dellefave L
    Trends Cardiovasc Med; 2009 Jan; 19(1):17-21. PubMed ID: 19467449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy.
    Hoedemaekers YM; Caliskan K; Michels M; Frohn-Mulder I; van der Smagt JJ; Phefferkorn JE; Wessels MW; ten Cate FJ; Sijbrands EJ; Dooijes D; Majoor-Krakauer DF
    Circ Cardiovasc Genet; 2010 Jun; 3(3):232-9. PubMed ID: 20530761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.
    Kamisago M; Sharma SD; DePalma SR; Solomon S; Sharma P; McDonough B; Smoot L; Mullen MP; Woolf PK; Wigle ED; Seidman JG; Seidman CE
    N Engl J Med; 2000 Dec; 343(23):1688-96. PubMed ID: 11106718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.
    Kolokotronis K; Kühnisch J; Klopocki E; Dartsch J; Rost S; Huculak C; Mearini G; Störk S; Carrier L; Klaassen S; Gerull B
    Hum Mutat; 2019 Aug; 40(8):1101-1114. PubMed ID: 30924982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype.
    Probst S; Oechslin E; Schuler P; Greutmann M; Boyé P; Knirsch W; Berger F; Thierfelder L; Jenni R; Klaassen S
    Circ Cardiovasc Genet; 2011 Aug; 4(4):367-74. PubMed ID: 21551322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
    Nakashima Y; Kubo T; Sugiura K; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kimura A; Doi YL; Kitaoka H
    Circ J; 2020 Sep; 84(10):1846-1853. PubMed ID: 32830170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the sarcomere gene MYH7 in Ebstein anomaly.
    Postma AV; van Engelen K; van de Meerakker J; Rahman T; Probst S; Baars MJ; Bauer U; Pickardt T; Sperling SR; Berger F; Moorman AF; Mulder BJ; Thierfelder L; Keavney B; Goodship J; Klaassen S
    Circ Cardiovasc Genet; 2011 Feb; 4(1):43-50. PubMed ID: 21127202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
    Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
    Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
    Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
    Witjas-Paalberends ER; Piroddi N; Stam K; van Dijk SJ; Oliviera VS; Ferrara C; Scellini B; Hazebroek M; ten Cate FJ; van Slegtenhorst M; dos Remedios C; Niessen HW; Tesi C; Stienen GJ; Heymans S; Michels M; Poggesi C; van der Velden J
    Cardiovasc Res; 2013 Aug; 99(3):432-41. PubMed ID: 23674513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
    J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel MYH7 mutation in a family with cardiomyopathy presenting with restrictive physiology and varying degrees of left ventricle hypertrophy.
    Yu BL; Xiang R; Hu D; Peng DQ
    Eur Heart J; 2015 Jan; 36(3):178. PubMed ID: 25422285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.